Latest News

Second Patient Dies Following Treatment With Sarepta’s DMD Gene Therapy Elevidys
Second Patient Dies Following Treatment With Sarepta’s DMD Gene Therapy Elevidys

June 17th 2025

In light of the patient’s death, Sarepta put a temporary hold on shipments of Elevidys for patients who are nonambulatory.

Myasthenia Gravis Awareness Month 2025: CAR-T Continues Steady Progress
Myasthenia Gravis Awareness Month 2025: CAR-T Continues Steady Progress

June 17th 2025

Eugenio Galli, MD, PhD, on Reexamining Frailty as a Barrier to CAR-T Treatment
Eugenio Galli, MD, PhD, on Reexamining Frailty as a Barrier to CAR-T Treatment

June 16th 2025

John Evans, MBA, CEO of Beam Therapeutics
Beam’s Base-Editing HSC Therapy BEAM-101 Raises HbF Levels in Patients With Sickle Cell Disease

June 16th 2025

Matthew Ku, MBBS, FRACP, RACP, FRCPA/RCPA, PhD, an associate professor and the lymphoma stream lead at St Vincent’s Hospital
The Safety Profile of J&J's CD19/CD20-Targeted CAR-T Therapy JNJ-90014496 in R/R LBCL

June 15th 2025

Video Interviews

Conference Coverage

View All
Eugenio Galli, MD, PhD, on Reexamining Frailty as a Barrier to CAR-T Treatment
Eugenio Galli, MD, PhD, on Reexamining Frailty as a Barrier to CAR-T Treatment

June 16th 2025

John Evans, MBA, CEO of Beam Therapeutics
Beam’s Base-Editing HSC Therapy BEAM-101 Raises HbF Levels in Patients With Sickle Cell Disease

June 16th 2025

Matthew Ku, MBBS, FRACP, RACP, FRCPA/RCPA, PhD, an associate professor and the lymphoma stream lead at St Vincent’s Hospital
The Safety Profile of J&J's CD19/CD20-Targeted CAR-T Therapy JNJ-90014496 in R/R LBCL

June 15th 2025

Omotayo Fasan, MRCP, DTM&H, MBBS, the head of the clinical development program at Galapagos
Omotayo Fasan, MRCP, DTM&H, MBBS, on Evaluating CAR-T GLPG5101 in R/R NHL

June 15th 2025

All News

© 2025 MJH Life Sciences

All rights reserved.